BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/25/2020 10:20:16 AM | Browse: 1052 | Download: 2227
 |
Received |
|
2020-09-29 01:38 |
|
Peer-Review Started |
|
2020-09-29 01:39 |
|
First Decision by Editorial Office Director |
|
2020-11-08 06:02 |
|
Return for Revision |
|
2020-11-08 06:02 |
|
Revised |
|
2020-11-14 01:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-11-24 12:14 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-11-29 04:07 |
|
Articles in Press |
|
2020-11-29 04:07 |
|
Edit the Manuscript by Language Editor |
|
2020-12-03 21:49 |
|
Typeset the Manuscript |
|
2020-12-22 01:19 |
|
Publish the Manuscript Online |
|
2020-12-25 10:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in Bregs
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiong Sun, Yao Huang, Ya-Li Zhang, Dan Qiao and Yan-Cheng Dai |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 81873253 |
| Key clinical specialty construction project supported by Hongkou District Health Committee |
No. HKZK2020A01 |
| Sixth round of academic experience successors training project for Veteran Practitioner of Traditional Chinese Medicine, the document of the State Administration of Traditional Chinese Medicine |
2017 No. 29 |
|
| Corresponding Author |
Yan-Cheng Dai, PhD, Chief Doctor, Department of Gastroenterology, Shanghai Traditional Chinese Medicine Integrated Hospital, Shanghai University of Traditional Chinese Medicine, No. 230 Baoding Road, Shanghai 200082, China. daiyancheng2005@126.com |
| Key Words |
Vasoactive intestinal peptide; Ulcerative colitis; Interleukin-10; Bregs; Pathogenesis; |
| Core Tip |
The pathophysiology of ulcerative colitis remains unclear. Vasoactive intestinal peptide (VIP) is a neuropeptide, which has strong regulatory activity on intestinal immunity. With further clarity on the mechanism of the regulation of interleukin-10 expression by VIP in Bregs in colitis patients, we believe that VIP can provide a novel strategy for the clinical treatment of ulcerative colitis. |
| Publish Date |
2020-12-25 10:20 |
| Citation |
Sun X, Huang Y, Zhang YL, Qiao D, Dai YC. Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in Bregs. World J Gastroenterol 2020; 26(48): 7593-7602 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i48/7593.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i48.7593 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
